FDA Drug Application (077246) for DANAZOL by LANNETT

Back to FDA Applications sponsored by LANNETT

Application Number077246
Product Number001
FormCAPSULE;ORAL
Dosage200MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDANAZOL
Active IngredientDANAZOL

Active IngredientCount
List of drugs with Active Ingredient DANAZOL2


Back to FDA Applications sponsored by LANNETT